← Leaderboards
H. Joachim Deeg
Fred Hutchinson Cancer Research Center
$6,774,714
Attributed
$6,774,714
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $860.9K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,774,714 · 7
By mechanism
R01$4,991,304 · 3
P01$1,229,174 · 2
R21$544,720 · 1
N01$9,516 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Rainer F. Storb$23,835,935
- Beverly J Torok-Storb$23,179,515
- Peter A. Mc Sweeney$1,063,126
- Lauri M. Burroughs$850,274
- Robert Nash$887,415
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsHematopoieticPreventPatternHuman SubjectChronicHuman Therapy EvaluationTransplantationT-LymphocyteLeadAcuteMarrowCyclophosphamideIn VivoToxic EffectDyserythropoietic AnemiaAllogenicConditioningReportingMortality Vital StatisticsBusulfanDysmyelopoietic SyndromesIn VitroTransplant Recipients
Grant awards (24)
Hematopoietic Cell Transplantation and Iron Overload$417,143
R01 · FY2013 · HL · contact PI
Hematopoietic Cell Transplantation and Iron Overload$438,137
R01 · FY2012 · HL · contact PI
Hematopoietic Cell Transplantation and Iron Overload$442,525
R01 · FY2011 · HL · contact PI
Hematopoietic Cell Transplantation and Iron Overload$461,487
R01 · FY2010 · HL · contact PI
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes$164,827
P01 · FY2010 · HL · contact PI
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes$162,131
P01 · FY2009 · HL · contact PI
Cell Death and Clonal Survival in Myelodysplastic Syndr*$410,088
R01 · FY2008 · HL · contact PI
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes$156,441
P01 · FY2008 · HL · contact PI
Cell Death and Clonal Survival in Myelodysplastic Syndr*$410,088
R01 · FY2007 · HL · contact PI
WT1 Expression in Patients with MDS Treated with ATG an*$268,352
R21 · FY2007 · CA · contact PI
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes$166,933
P01 · FY2007 · HL · contact PI
Cell Death and Clonal Survival in Myelodysplastic Syndr*$422,336
R01 · FY2006 · HL · contact PI
WT1 Expression in Patients with MDS Treated with ATG an*$276,368
R21 · FY2006 · CA · contact PI
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes$162,201
P01 · FY2006 · HL · contact PI
Cell Death and Clonal Survival in Myelodysplastic Syndr*$432,500
R01 · FY2005 · HL
TRANSPLANTS FOR MYELODYSPLASIA AND MYELOFIBROSIS$416,641
P01 · FY2003 · HL
NOVEL THERAPEUTIC STRATEGIES IN MYELODYSPLASTIC SYNDROME$389,250
R01 · FY2003 · CA
NOVEL THERAPEUTIC STRATEGIES IN MYELODYSPLASTIC SYNDROME$389,250
R01 · FY2002 · CA
TRANSPLANTS FOR MYELODYSPLASIA AND MYELOFIBROSIS$0
P01 · FY2002 · HL
NOVEL THERAPEUTIC STRATEGIES IN MYELODYSPLASTIC SYNDROME$389,250
R01 · FY2001 · CA
TRANSPLANTS FOR MYELODYSPLASIA AND MYELOFIBROSIS$0
P01 · FY2001 · HL
NOVEL THERAPEUTIC STRATEGIES IN MYELODYSPLASTIC SYNDROME$389,250
R01 · FY2000 · CA
CANCER FOLLOWING BONE MARROW TRANSPLANTATION$4,758
N01 · FY2000 · CP
CANCER FOLLOWING BONE MARROW TRANSPLANTATION$4,758
N01 · FY2000 · CP